Tech News
← Back to articles

FDA removes warning label from hormone-based menopause drugs, sidestepping usual process

read original more articles

The 22-year-old FDA warning advised doctors that hormone therapy increases the risk of blood clots, heart problems, and other health issues. Hormone-based drugs used to treat hot flashes and other menopause symptoms will no longer carry a bold warning label about stroke, heart attack, dementia, and other serious risks, the Food and Drug Administration announced Monday.